• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降血脂药物。第4部分:降血脂剂异丙基-[4'-(对氯苯甲酰基)-2-苯氧基-2-甲基]-丙酸酯(LF 178)在大鼠、狗和人体内的代谢命运。

Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.

作者信息

Brodie R R, Chasseaud L F, Elson F F, Franklin E R, Taylor T

出版信息

Arzneimittelforschung. 1976;26(5):896-901.

PMID:989365
Abstract

The excretion and plasma concentrations of radioactivity and chromatographic patterns of radioactive components in plasma and excreta have been compared in rats, dogs and man after oral doses of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF 178; procetofene; Lipanthyl¿). 2. In rats, 48.1% of a single dose of 25 mg/kg was excreted in the urine, and 48.6% in the faeces. In dogs, 23.1% of a single dose at the same level was excreted in the urine, and 71.8% in the faeces, but 88.1% of a dose of 300 mg to man was excreted in the urine, and only 5.1% in the faeces. Peak levels of radioactivity in the plasma of all three species studied were similar (20--30 mug/ml) after doses at these levels and concentrations declined thereafter with half-lives of 7--24 h in rats and dogs, and 7 h in man. The half-life of radioactivity concentrations in rat plasma was not altered by repeated daily doses for 7 days. 3. Whole-body autoradiography of rats showed that radioactivity was largely associated with the liver, kidneys and gut, which are the organs of biotransformation and excretion, although relatively high levels were present in lungs and blood, and small amounts of radioactivity had a widespread distribution into some peripheral tissues during 2--7 h after dosing. 4. The available chromatographic evidence indicated that the most important biotransformation pathway appeared to be ester hydrolysis to LF 178 acid and formation of water soluble conjugates of this acid. This pathway appeared similar to that of the related drug clofibrate (ethyl p-chlorophenoxyisobutyrate).

摘要

给大鼠、狗和人口服降血脂药物异丙基-[4'-(对氯苯甲酰基)-2-苯氧基-2-甲基]-丙酸酯(LF 178;普罗布考;力平之®)后,比较了放射性的排泄和血浆浓度以及血浆和排泄物中放射性成分的色谱图。2. 在大鼠中,单次给予25 mg/kg剂量后,48.1%经尿液排泄,48.6%经粪便排泄。在狗中,相同剂量水平下单次给药的23.1%经尿液排泄,71.8%经粪便排泄,但给予人300 mg剂量时,88.1%经尿液排泄,仅5.1%经粪便排泄。在所研究的所有三个物种中,这些剂量水平下血浆中放射性的峰值水平相似(20 - 30 μg/ml),此后浓度下降,大鼠和狗的半衰期为7 - 24小时,人的半衰期为7小时。大鼠血浆中放射性浓度的半衰期不受连续7天每日重复给药的影响。3. 对大鼠的全身放射自显影显示,放射性主要与肝脏、肾脏和肠道相关,这些是生物转化和排泄器官,尽管肺部和血液中也存在相对较高水平,给药后2 - 7小时少量放射性广泛分布到一些外周组织中。4. 现有的色谱证据表明,最重要的生物转化途径似乎是酯水解为LF 178酸并形成该酸的水溶性结合物。该途径似乎与相关药物氯贝丁酯(对氯苯氧异丁酸乙酯)的途径相似。

相似文献

1
Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.降血脂药物。第4部分:降血脂剂异丙基-[4'-(对氯苯甲酰基)-2-苯氧基-2-甲基]-丙酸酯(LF 178)在大鼠、狗和人体内的代谢命运。
Arzneimittelforschung. 1976;26(5):896-901.
2
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
3
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
4
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.新型降胆固醇化合物S-8921在大鼠和犬体内的处置与代谢
Arzneimittelforschung. 1998 Oct;48(10):995-1006.
5
Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.新型中枢抑制剂8-氯-6-(邻氯苯基)-1-甲基-4H-三唑并[4,3-α][1,4]苯二氮䓬(三唑仑)的代谢。I. 在大鼠、狗和猴体内的吸收、分布及排泄
Xenobiotica. 1979 Jul;9(7):415-28. doi: 10.3109/00498257909038746.
6
Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.新型抗癌药物酒石酸长春瑞滨在小鼠、大鼠和犬静脉注射后的处置情况。
Arzneimittelforschung. 1993 Dec;43(12):1367-77.
7
Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178).抗血脂药物。第2部分:一种新型强效抗血脂药物异丙基-[4'-(对氯苯甲酰基)-2-苯氧基-2-甲基]-丙酸酯(LF178)的实验研究。
Arzneimittelforschung. 1976;26(5):889-94.
8
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
9
Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.普卢利沙星的药代动力学。首次通信:单次给药后在大鼠、狗和猴子体内的吸收、分布及排泄情况
Arzneimittelforschung. 1997 Mar;47(3):276-84.
10
Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.酮色林在大鼠、兔和犬体内的药代动力学及组织分布
Arzneimittelforschung. 1988 Jun;38(6):775-84.

引用本文的文献

1
Distribution of fenofibric acid in lipoprotein fractions of patients.非诺贝特酸在患者脂蛋白组分中的分布。
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):287-94. doi: 10.1007/BF03189353.
2
Antiviral activity of antilipidemic compounds on herpes simplex virus type 1.抗血脂化合物对1型单纯疱疹病毒的抗病毒活性。
Antimicrob Agents Chemother. 1980 Aug;18(2):269-75. doi: 10.1128/AAC.18.2.269.
3
Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb.非诺贝特每日单次剂量治疗对IIb型高脂血症患者血浆脂蛋白的影响。
Eur J Clin Pharmacol. 1988;34(1):25-8. doi: 10.1007/BF01061412.
4
Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.
Drugs. 1990 Aug;40(2):260-90. doi: 10.2165/00003495-199040020-00007.